Inventor · disambiguated record
Michael Wetter
Also filed as: WETTER MICHAEL · WETTER MICHAEL L · WETTER MICHAEL LUKAS
17 granted patents·4 pending applications·97 citations·filing 2009–2024
93Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA13GLYCOVAXYN AG4LIMMATECH BIOLOGICS AG2FERNANDEZ FABIANA1WACKER MICHAEL1
Top patents by PatentIndex Score
21 records- 0196US10940192B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Mar 9, 2021·11 cites·20 claims
- 0294US9700612B2Polysaccharide and uses thereofGLYCOVAXYN AG·Filed 2015·Granted Jul 11, 2017·27 cites·20 claims
- 0393US11738076B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Granted Aug 29, 2023·2 cites·22 claims
- 0493US10583185B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Mar 10, 2020·12 cites·20 claims
- 0593US10441647B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Oct 15, 2019·13 cites·20 claims
- 0692US8871491B2Capsular gram-positive bacteria bioconjugate vaccinesWACKER MICHAEL·Filed 2011·Granted Oct 28, 2014·12 cites·17 claims
- 0787US9585950B2Capsular gram-positive bacteria bioconjugate vaccinesGLYCOVAXYN AG·Filed 2014·Granted Mar 7, 2017·5 cites·25 claims
- 0885US12214029B2Polysaccharide and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Granted Feb 4, 2025·0 cites·20 claims
- 0984US8895014B2Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cellsFERNANDEZ FABIANA·Filed 2009·Granted Nov 25, 2014·11 cites·13 claims
- 1081US2024277824A1Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 1177US12076385B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Sep 3, 2024·0 cites·22 claims
- 1277US10195262B2Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Feb 5, 2019·3 cites·8 claims
- 1371US11944675B2Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Apr 2, 2024·0 cites·7 claims
- 1471US10835592B2Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Nov 17, 2020·0 cites·9 claims
- 1570US11236136B2Methods of producing glycosylated proteinsLIMMATECH BIOLOGICS AG·Filed 2016·Granted Feb 1, 2022·1 cites·13 claims
- 1665US11484582B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Nov 1, 2022·0 cites·20 claims
- 1765US10307473B2Capsular gram-positive bacteria bioconjugate vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jun 4, 2019·0 cites·8 claims
- 1859US2022242919A1Methods of producing glycosylated proteinsLIMMATECH BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 1957US10973901B2Production of recombinant vaccine in E. coli by enzymatic conjugationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Apr 13, 2021·0 cites·16 claims
- 2049US2015273043A1Production of recombinant vaccine in e.coli by enzymatic conjugationGLYCOVAXYN AG·Filed 2013·Application pending·0 cites
- 2142US2015238596A1Bioconjugates comprising modified antigens and uses thereofGLYCOVAXYN AG·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Wetter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →